Treatment of TB

Byscientist
Decorative cardboard appliques of sick human figure under pills and capsules near syringe and stethoscope on green background

Tuberculosis (TB) is the no 1 infectious disease killer all over the world but there has not been much development in new therapeutics till recently.

There are 2 ways to address TB. Vaccine and therapeutics.

The current vaccine for TB has been BCG which is not very effective in adults is still useful in children and given to children regularly. But there has not been much development – there is no incentive for development….

On the therapeutics, most of the drugs that are used have been around since many years and are not very effective…the standard drugs are Isoniazid, Rifampin, Pyrazinamide, Ethambutol are sued for a long treatment regimen and the MDR are treated for longer with additional drugs.

Now there are other options:

M27 vaccine that is derived from 2 Mycobacterium Tuberculosis strains is in Phase 3

For MDR Tb: Sudapyridine for MDR-TB which is being presented as a superior to Bedaquiline

Quabodepistat – A decrprenylphospho-beta-D-ribose-2-oxidase inihibitor is another drug being considered and may become the front line in treatment of TB since it has a short treatment time.

There are other late stage drugs that are in development so the future for TB is beginning to look good.

https://www.globaldata.com/newsletter/details/trials-to-watch-phase-iii-tb-vaccines-and-mdr-tb-treatments

Similar Posts

  • Pharmacologically active constituents in plants

    Byscientist

    There are many compounds in plants that are active in animals and humans. In broad category, all of these compounds listed below are listed. But, lets take it one at a time. Proanthocyanidins Cyanogenic glycosides Polysaccharides Glucosinolates Bitters Alkaloids Coumarins Saponins Phenols Volatile oils Flavonoids Tannins Anthraquinones Cardiac glycosides Proanthocyanidins: These molecules give the plants…

  • |

    Phages as antibacterial

    Byscientist

    Bacteriophages are viruses that attack bacteria killing them. They are inanimate and can be considered dead till they infect the bacteria where they multiply. Phages were approved by the FDA in 2006 for their application in food to control Listeria infections. Link to paper: https://www.gastrojournal.org/article/S0016-5085%2806%2902235-9/fulltext This has continued for sometime, since multiple strains can be…

  • |

    Muscarinic drugs and receptors

    Byscientist

    There are many G-protein coupled receptors and one of the major categories for neurological drug development are called muscarinic receptors because they were first known to be activated by a mushroom alkaloid called muscarine. The isolation and characterization of muscarine was first reported by chemists in 1869! Muscarine works by mimicking the neurotransmitter acteylcholine on…

  • |

    Open source protein models

    Byscientist

    A company called Profluent (profluent.bio) has been developing protein models that can be used for designing new proteins (https://www.nature.com/articles/s41587-022-01618-2), modeling of new CRISPR-Cas sequences (https://www.nature.com/articles/s41586-025-09298-z) and developing LLM for protein generation (https://www.biorxiv.org/content/10.1101/2025.11.12.688125v1.article-info). What is amazing is that they have open sourced all their models and Profluent-E1 is available in GitHub to download and use. (https://github.com/Profluent-AI/E1)…

  • Tau

    Byscientist

    There is so much known about the Tau protein but we still have a lot to understand about its role in diseases. In disorders where Tau is the major protein that is involved – the primary taupathies – such as Pick’s disease and Progressive supranuclear palsy, it is clear that Tau has a major effect…